Open access
Open access
Powered by Google Translator Translator

RCT: Once-weekly, high-dose semaglutide is effective for improving overweight or obesity among non-diabetic adults

11 Feb, 2021 | 02:09h | UTC

Once-Weekly Semaglutide in Adults with Overweight or Obesity – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Semaglutide Plus Lifestyle Change Shown Effective for Obesity – NEJM Journal Watch

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.